21
Safety and Gastrointestinal Effects of Intravenous Methylnaltrexone
Condition(s): Healthy Volunteers Last Updated: July 18, 2011Completed
40 Clinical Trials for: “Methylnaltrexone”, Page 2 of 2
Hide Studies Not Seeking New Volunteers
22
Study of Intravenous (IV) Methylnaltrexone Bromide (MNTX) in the Treatment of Post-Operative Ileus (POI).
Condition(s): Post-Operative Ileus (POI) Last Updated: July 17, 2011Completed
23
Opioids and Esophageal Function
Condition(s): Pharyngeal Dysfunction; Esophageal Dysfunction Last Updated: December 8, 2011Completed
24
Study of Methylnaltrexone (MNTX) for the Relief of Constipation
Condition(s): Advance Illness Patients With OIC Last Updated: July 18, 2011Completed
25
A Study of Oral Methylnaltrexone (MNTX) for the Treatment of Opioid-Induced Constipation in Subjects With Chronic, Non-Malignant Pain
Condition(s): Opioid-Induced Constipation Last Updated: July 15, 2011Active, not recruiting
26
Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative Ileus
Condition(s): Post Operative Bowel Dysfunction Last Updated: July 22, 2011Completed
27
Naloxone and Intravenous Methylnaltrexone Effects on Bladder Function
Condition(s): Healthy Males Last Updated: July 18, 2011Completed
28
Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone in Volunteers With Impaired Hepatic Function
Condition(s): Liver Dysfunction Last Updated: July 17, 2011Completed
29
Intravenous (IV) Methylnaltrexone (MNTX) in the Prevention of Post-Operative Ileus
Condition(s): Postoperative Ileus Last Updated: July 18, 2011Completed
30
Tolerance and Pharmacokinetics Study of MNTX Tablets
Condition(s): Normal Healthy Volunteers Last Updated: July 17, 2011Completed
31
Effect of Cimetidine on the Single-Dose PK of IV- Administered MNTX
Condition(s): Healthy Adult Subjects Last Updated: July 18, 2011Completed
32
Evaluate the Pharmacokinetics (PK) of Methylnaltrexone (MNTX) in Healthy Adult Subjects
Condition(s): Healthy Adult Subjects Last Updated: July 17, 2011Completed
33
Study Evaluating Long-Term Safety Of MOA-728 In Subjects With Opioid-Induced Constipation
Condition(s): Constipation Last Updated: June 3, 2011Completed
34
Study of the Pharmacokinetics of Intravenous Administered 14C-MNTX
Condition(s): Healthy Male Volunteers Last Updated: July 17, 2011Completed
35
Open-Label Treatment Extension of Protocol MNTX 302
Condition(s): Terminal Illness Last Updated: July 18, 2011Completed
36
Open-Label Treatment Extension of Protocol MNTX 301
Condition(s): Terminal Illness Last Updated: July 18, 2011Completed
37
Methylnaltrexone in Patients With Opioid-Induced Bowel Dysfunction
Condition(s): Bowel Dysfunction Last Updated: July 18, 2011Completed
38
Study Evaluating Oral MOA-728 For The Treatment Of OIBD In Subjects With Chronic Non-Malignant Pain
Condition(s): Constipation Last Updated: July 22, 2011Completed
39
Study Evaluating Subcutaneous MOA-728 for the Treatment of Opioid-Induced Constipation (OIC) in Subjects With Chronic Non-Malignant Pain
Condition(s): Constipation Last Updated: September 7, 2011Completed
40
A Study Evaluating IV MOA-728 for the Treatment of POI In Subjects After Ventral Hernia Repair
Condition(s): Ileus Last Updated: July 22, 2011Completed
